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Available online 12 April 2014Abstract Stem cells, especially human embryonic stem cells (hESCs), are useful models to study molecular mechanisms of
human disorders that originate during gestation. Alcohol (ethanol, EtOH) consumption during pregnancy causes a variety of
prenatal and postnatal disorders collectively referred to as fetal alcohol spectrum disorders (FASDs). To better understand the
molecular events leading to FASDs, we performed a genome-wide analysis of EtOH's effects on the maintenance and
differentiation of hESCs in culture. Gene Co-expression Network Analysis showed significant alterations in gene profiles of
EtOH-treated differentiated or undifferentiated hESCs, particularly those associated with molecular pathways for metabolic
processes, oxidative stress, and neuronal properties of stem cells. A genome-wide DNA methylome analysis revealed
widespread EtOH-induced alterations with significant hypermethylation of many regions of chromosomes. Undifferentiated
hESCs were more vulnerable to EtOH's effect than their differentiated counterparts, with methylation on the promoter regions
of chromosomes 2, 16 and 18 in undifferentiated hESCs most affected by EtOH exposure. Combined transcriptomic and DNA
methylomic analysis produced a list of differentiation-related genes dysregulated by EtOH-induced DNA methylation changes,
which likely play a role in EtOH-induced decreases in hESC pluripotency. DNA sequence motif analysis of genes epigenetically
altered by EtOH identified major motifs representing potential binding sites for transcription factors. These findings should
help in deciphering the precise mechanisms of alcohol-induced teratogenesis.
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While moderate alcohol consumption by adults has proven
health benefits (French and Zavala, 2007; Gunzerath et al.,
2004), excessive alcohol consumption has numerous detri-
mental effects, making it the 3rd leading cause of the global
burden of injury and disease (Lim et al., 2012). Moreover,
even moderate alcohol consumption during pregnancy is
known to cause fetal alcohol spectrum disorders (FASDs),
collectively the largest preventable set of birth defects (May
et al., 2009; Riley et al., 2011). FASDs are characterized by
prenatal and postnatal growth restriction, craniofacial
dysmorphology, and structural/functional abnormalities of
the central nervous system (CNS) (Hoyme et al., 2005). The
severity of the defects depends on pregnant mothers' alcohol
(ethanol, EtOH) drinking patterns and doses. For example,
many women keep drinking until they realize they are
pregnant (4–6 weeks), and some of them quit or decrease
their alcohol use only by mid-pregnancy (Day et al., 1989;
Floyd et al., 2005; Floyd et al., 2009) therefore many fetuses
are exposed to EtOH during early stages of pregnancy. EtOH
readily crosses the placenta; consequently, peak fetal blood
EtOH levels are similar to the mother (Thomas and Riley,
1998). Although EtOH clearance is increased in pregnancy
(Nava-Ocampo et al., 2004; Shankar et al., 2007), the EtOH
elimination capacity of the fetus is low, particularly in the
early stages of pregnancy (Pikkarainen, 1971), and EtOH
remains trapped in the amniotic fluid leading to reabsorption
by the fetus, thereby prolonging exposure time (Brien et al.,
1983; Nava-Ocampo et al., 2004).
Epigenetic modifications, DNA methylation in particular,
regulate key developmental processes including germ cell
imprinting and stem cell maintenance/differentiation and
play a crucial role in the early periods of embryogenesis
(Bartolomei, 2003; Kiefer, 2007; Kondo, 2006; Surani et al.,
2007). DNA methylation is also a fundamental aspect of
programmed fetal development, determining cell fate, pattern
formation, terminal differentiation andmaintenance of cellular
memory required for developmental stability (Cavalli, 2006;
Kafri et al., 1992). Moreover, aberrant epigenetic changes
in response to environmental stimuli have been shown to
contribute to developmental disorders (Zhao et al., 2007).
Several hypotheses involving alcohol (ethanol, EtOH)-
induced changes in genetic and epigenetic regulation of cells
as possiblemolecularmechanisms of FASDs have been recently
advanced (Haycock, 2009; Haycock and Ramsay, 2009; Kleiber
et al., 2012; Luo, 2009; Ramsay, 2010; Zeisel, 2011). However,
the precise mechanisms by which EtOH alters the transcrip-
tional landscape are still largely unknown. In addition, EtOH
dose-dependently influences the molecular, cellular, and
physiological regulation of adult stem cells which likely
contributes to the deleterious consequences of excessive
alcohol consumption in adults (Crews et al., 2003; Crews and
Nixon, 2003; Nixon et al., 2010; Roitbak et al., 2011).
Human stem cells may serve as useful models for
delineating the molecular effects of EtOH, especially given
the ethical issues of administering alcohol to pregnant women.
Alcohol researchers have already taken advantage of these
models by observing the consequences of EtOH administration
on stem cell differentiation (Garic et al., 2011; Miranda, 2012;
Nash et al., 2012; Palmer et al., 2012; Vangipuram and Lyman,
2012). However, genome and methylome-wide studies ofEtOH's effects on hESCs have not been reported. Here we
show that EtOH can induce DNA methylomic changes in hESCs
that may have a significant impact on gene regulatory
mechanisms potentially involved in stem cell maintenance
and differentiation, and by extension, in proper embryo
development processes.
Material and methods
Cell culture
Human embryonic stem cells H1 and H9 were obtained from
UCLA Broad Stem Cell Research Center through a license
agreement with WiCell Research Institute. Cells were
initially grown and propagated in hESC growth medium —
Dulbecco's Modified Eagle's Medium/Ham's nutrient mixture
F12 (DMEM/F12) supplemented with 20% Knockout Serum
Replacement (KSR), 1 mM glutamate, 1% non-essential amino
acids, 0.1 mM β-mercaptoethanol and 5 ng/mL basic fibro-
blast growth factor (bFGF) with mitotically inactivated mouse
embryonic fibroblast (MEF) feeder layer. Before treatment,
cells were transferred to mTeSR1 medium on matrigel-coated
100 mm plates without feeder cells using standard conditions
(Stem Cell Technologies, Vancouver, BC, Canada) (Xu et al.,
2001).
Embryoid body (EB) formation
To induce differentiation of hESCs, cells cultured in mTeSR1
medium were dissociated by using Accutase (Stem Cell
Technologies, Vancouver, BC, Canada) and washed three
times with plain DMEM/F12 medium. Harvested cells were
resuspended in hESC growth medium without bFGF supple-
ment and transferred to ultra-low attachment plates to form
embryoid bodies (Corning, Inc., Corning, NY). Aggregated
embryoid bodies were kept for designated time period up to
10 days with daily media change.
Ethanol treatment
Cultured cells were treated with different concentrations
of EtOH (20 or 50 mM) for 24 or 48 h. These EtOH
concentrations were chosen for their physiological relevance,
20 mM is equivalent to DUI level and 50 mM falls within levels
measured in alcoholics (Jones and Sternebring, 1992). The 24
or 48 h exposure time was chosen to mimic the likely
prolonged exposure to maternal EtOH, based on the poor
EtOH elimination capacity of the fetus during early develop-
ment (Pikkarainen, 1971). Calculated volume of absolute
EtOH (Fisher Scientific, Pittsburg, PA) was diluted in culture
media and cells were fed daily with fresh media. Analysis was
done in biological duplicates. In some experiments, cells were
treated with 1 μM of 5-azacytidine (Sigma, St. Louis, MO)
simultaneously with 20 mM EtOH for 24 h.
Gene expression microarray
Total RNA was prepared by using an RNeasy kit (Invitrogen,
Carlsbad, CA). Sampleswere prepared in biological triplicates.
Equal amount from each samplewas subjected to biotinylation
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(Enzo Life Sciences, Farmingdale, NY, USA). Equal amount
cRNA from each sample was labeled, purified and fragmented
by using a GeneChip Sample Cleanup Module (Affymetrix,
Santa Clara, CA, USA). Following themanufacturer's protocols,
the Human Genome U133 Plus 2.0 Array (Affymetrix, Santa
Clara, CA) was applied for gene expression analysis (UCLA
Microarray Core Facility).
DNA methylation analysis
Total genomic DNA was isolated and 200 ng of DNA was
subjected to methylated DNA quantification assay by using a
MethylFlash methylated DNA quantification kit (Epigentek
Inc., Brooklyn, NY). % 5-methylcytosine was quantified against
a positive standard provided. Alternatively, total genomic
DNA was isolated and processed for genome-wide DNA
methylation sequencing analysis by Zymo Research (Irvine,
CA). Briefly, DNA samples were fragmented and end-modified
to add an adaptor. After size selection, bisulfite conversion
was performed and amplification was done for library
construction. Next-generation bisulfite sequencing was done
to obtain raw data. After sequence quality check, bioinfor-
matic processing was performed.
Weighted Gene Co-expression Network Analysis
(WGCNA) and network construction
WGCNA was performed by following the tutorial written by
Langfelder and Horvath (Langfelder and Horvath, 2008).
Co-expression networks were built using the R program.
Clusters of genes that behaved similarly were grouped into
different color modules. Modules were annotated by the
Database for Annotation, Visualization and Integrated Discovery
(DAVID) Functional Annotation Bioinformatics Microarray Tools
(Huang da et al., 2009). Pathway analysis was done by the
Kyoto Encyclopedia of Genes and Genomes (KEGG). HIVE
0.0.11 was downloaded and ran on Mac OS X 10.7.4. Edges
and nodes were normalized to uploaded data. STAMP motif
analysis was performed according to the tutorial provided by
authors (Mahony et al., 2007; Mahony and Benos, 2007). The
top five sequence matches were output in the TRANSFAC
Transcription Factor Binding Sites database (v.1.1.3).
Quantitative RT-PCR
RNA was purified using the RNeasy Kit. cDNA was synthesized
using the iScript cDNA Synthesis kit (Bio-Rad Laboratories,
Inc., Hercules, CA). For the PCR reactions, a 2X Roche
LightCycler 480 SYBR Green I Master Mix was used and analysis
was done with the LightCycler 480 RT-PCRmachine. Reactions
were done in triplicate using 0.4 μL of cDNA (out of 40 μL of
cDNA from 2 μg of total RNA) as a template in a 10 μL reaction
volume. Each experiment was repeated at least three times.
Immunofluorescence (IF) analysis
Cells were fixed in 100% methanol for 15 min at room
temperature. For staining, samples were permeabilized for
15 min in freshly prepared IF staining solution (PBS containing0.02% saponin, 1% bovine serum albumin, and 0.05% sodium
azide, 0.2% Triton X-100). Samples were then incubated in a
37 °C water bath for 1 h with a primary antibody diluted in IF
solution. Antibodies in an ES characterization kit were
purchased from EMD-Millipore Chemicals (Billerica, MA) and
used in 1:50 dilution as recommended by the manufacturer.
The same isotype Ig was used as background control. Samples
were transferred to a 1:500 dilution of goat anti-mouse IgG
rhodamine (Thermo Scientific, Waltham, MA) in IF solution
and incubated for in 37 °C water bath for 1 h. Processed
samples were mounted on a glass slide with mounting medium
with DAPI (Vectashield, Burlingame, CA) and visualized with
an inverted light microscope (Olympus IX81 and CellSens
Dimension software, Center Valley, PA).
Statistical analysis
Group differences were evaluated by unpaired Student's t-test
or one-way analysis of variance (ANOVA), where appropriate.
The Fisher Exact test was used to measure the gene-
enrichment in annotation terms. E-value comparing common
motif and associated transcriptional factors was calculated
based on the Wasserman and Sandelin method (Wasserman
and Sandelin, 2004). p-Values within WGCNA were calculated
based on a regression-based p-value for assessing the
statistical significance between the matrix X and the sample
trait T, where matrix X is ‘network nodes times column
indices’ of all genes (X = n × m).
Data access
Gene expression data have been submitted to the NCBI Gene
Expression Omnibus (GEO) repository (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE45036) under accession
number GSE45036.
Results
Transcriptomic profiling of EtOH effects on hESCs
A genome-wide microarray (Affymetrix Human Genome U133
Plus 2.0 Array platform) was used to generate gene expression
data for hESCs in order to compare the concentration-
dependent effects of EtOH (0, 20 or 50 mM) on two different
hESC lines, H1 and H9 (Fig. 1). The H1 and H9 cell lines were
derived from male and female fetuses, respectively (Thomson
et al., 1998). To find co-expression modules related to EtOH
treatment and differentiation status we used the Weighted
Gene Co-Expression Network Analysis (WGCNA) (Fig. 1A)
(Langfelder and Horvath, 2008; Zhang and Horvath, 2005).
We also examined the molecular signatures of differentiation
from undifferentiated stem cells to embryonic bodies (EBs) in
the absence of EtOH treatment. Comparisons of H1 and H9
heatmaps from representative modules are shown (Fig. 1B).
We selected three representative modules that showed the
same pattern of expression changes after EtOH treatment in
both H1 and H9 hESCs. This is to demonstrate an example of
EtOH-induced alterations in gene signatures independent of
cell lines. Volcano plots (Fig. 1D) demonstrated similarities in
EtOH's effects on expression of genes in the two hESC lines,
794 O. Khalid et al.however, the changes were consistently greater in the H9 line
compared to the H1 line. Based on these data, we subse-
quently focused on molecular analysis of differentiation and
EtOH application in the H9 hESC line.We also chose to focus on
the lower concentration of EtOH (20 mM) because a similar
blood level of EtOH, which is just above the driving limit(Jones and Sternebring, 1992), is easily achieved after
excessive drinking by women (Bedford et al., 2006). The
24 hour duration of EtOH exposure was chosen because in
addition to the low EtOH elimination capacity of the fetus,
particularly in the early stages of pregnancy (Pikkarainen,
1971), EtOH remains trapped in the amniotic fluid leading to
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et al., 1983).
Using unsupervised hierarchical clustering with WGCNA
consensus analysis we found twenty-four distinct modules
(Fig. 1C). Note that two of the representative modules, light-
yellow and turquoise, showed consistent gene expression
correlations under three different conditions (during differen-
tiation without EtOH treatment, EtOH treatment in undiffer-
entiated hESCs and EtOH treatment in differentiated EBs)
(Fig. 1C, indicated with the asterisks). Thus, the light-yellow
module showed significant repression in differentiation,
whereas a turquoise module exhibited the opposite, suggesting
an essential role of genes in these modules during differenti-
ation and also in EtOH-induced molecular alterations. The
consensus module trait relationships are represented as
correlation values and significance (Fig. S1). Furthermore, to
delineate the top genes within these modules, we made a
Volcano plot comparing significance and fold change (Fig. 1D).
We analyzed natural clusters on the fourteen significant
modules using the R package cluster Profiler (Fig. 1E) (Yu
et al., 2012). It revealed that the modules formed distinct
ontological clusters with little to no overlap. We also identified
unique pathways for eachmodule using the Kyoto Encyclopedia
of Genes and Genomes (KEGG) Pathway (Fig. 1F) (Kanehisa
et al., 2012). These pathways include gene regulation,
metabolic pathways, neuronal activity and axon guidance as
well as pathways involved with epigenetic regulation. Notably,
we found that the turquoise module showed most significant
association with methyltransferase activity and the light-
yellow module showed the most significant association with
RNA polymerase II activity. This suggests that EtOH can
potentially affect transcriptional activity and regulation in
hESCs.
Interactions between genes based on co-expression
relationships were established by forming a gene network,
and these connections are represented by a HIVE plot, as a
traditional gene network, and a compressed hub gene
network (Figs. 1G–I) (Krzywinski et al., 2012). With highly
connected intramodular hub genes centrally located in the
module, the connections to the outer rim allow for further
elucidating the biological meaning of EtOH related modules.
For example, we have identified two top hub genes, SCUBE3
and SLC22A5 (presented as red dots in Figs. 1G–I), in aFigure 1 Transcriptomic profiling of gene signatures in EtOH-tr
analysis of hESC genes comparing EtOH (20 mM) treatment of hESC
undifferentiated and differentiated hESCs without EtOH treatment.
module cluster. (B) EtOH dose–response (at 0, 20 and 50 mM) c
representative modules. We selected three representative modules
treatment in both H1 and H9 hESCs. This is to demonstrate an examp
cell lines. (C) Cluster of the different modules in relation to differen
that showed consistent gene expression correlations are indicated by
significantly altered genes upon EtOH treatment between H1 and H
were analyzed by R package cluster Profiler and the result showed th
overlap. (F) Molecular pathway analysis using KEGG database showed
most affected clusters in (E). Fisher Exact test was adopted to measu
two independent groups can fall into one of two mutually exclusive c
proportions of those falling into each category differ by group (Huan
with the turquoise consensus module. Red dots showed two top h
representing the turquoise module. (I) The top hub genes, SCUBE3
centrality.representation of genes downregulated in H9 cells upon
EtOH treatment and differentiation. The SLC22A5 gene
functions in the transport of carnitine into the cell. More
specifically, SLC22A5 facilitates the function of protein
OCTN2, which is embedded in the cell membrane and acts
as a transporter for carnitine (Tamai et al., 1998). Carnitine
plays an essential role in transporting fatty acid from cytosol
into the mitochondrial matrix to be broken down into usable
metabolic energy. The SLC22A5 gene is therefore an impor-
tant regulator of fatty acid metabolism, and is necessary for
the maintenance of skeletal and cardiac muscle function
(Steiber et al., 2004). Mutations in the SLC22A5 gene can
cause systemic primary carnitine deficiency (Sonne et al.,
2012). Alcohol has the capacity to upregulate genes involved
in fatty acid metabolism similar to effects of glucagon when
blood sugar is low. SCUBE3 is a secreted and cell-associated
glycoprotein that can form either homo or hetero-oligomers
that can attach to the cell surface (Wu et al., 2004). It can act
either in an endocrine or autocrine/paracrine fashion in
regard to cell signaling. SCUBE3 can be expressed in human
osteoblasts (but not in non-osseous tissues), cardiac tissue,
and vascular endothelial cells (Wu et al., 2004). When SCUBE3
was overexpressed in mice, the animals were diagnosed with
cardiac hypertrophy (Yang et al., 2007). Thus, both of the top
hub genes have some involvement in cardiovascular function.EtOH-induced genome-wide DNA methylomic alter-
ations in hESCs
To determine the extent of EtOH's epigenetic effects on the
molecular regulation in hESCs, we initially measured the
effect of EtOH on global DNA methylation. Recent studies
have reported changes in methylation status upon EtOH
treatment (Sanchez-Alvarez et al., 2013; Zhou et al., 2011).
It has been shown that alcohol exposure alters migration and
important basic processes of neural stem cells (Zhou et al.,
2011). Their studies also showed that alcohol exposure altered
the methylation potential of genes that were initially in a
quiescent state (Zhou et al., 2011). To follow up on such
studies using hESCs, we performed a biochemical assay for
DNA methylation, which revealed a significant increase in
global DNA methylation after 48 h of EtOH (20 or 50 mM)eated or differentiating hESCs. (A) WGCNA consensus cluster
s in their undifferentiated or EB states, as well as comparing
Correlations of each respective comparison are shown below the
omparison between H1 and H9 cell lines using heatmaps of
that showed the same pattern of expression changes after EtOH
le of EtOH-induced alterations in gene signatures independent of
tiation and EtOH treatment. Turquoise and light-yellow modules
asterisks. (D) A Volcano plot identified the number of the most
9. (E) The top fourteen modules significantly affected by EtOH
at the modules formed distinct ontological clusters without any
the dot plot of the gene ontology unique to each module of the
re the gene-enrichment in annotation terms. When members of
ategories, Fisher Exact test was used to determine whether the
g da et al., 2009). (G) Hive plot of the gene network associated
ub genes — SCUBE3 and SLC22A5. (H) Standard gene network
and SLC22A5, and implicated genes based on maximal clique
796 O. Khalid et al.treatment (Fig. 2A). Global DNA methylation was slightly, but
not significantly higher with 50 mM compared to 20 mM EtOH
treatment. To further study the molecular effect of EtOH on
DNAmethylomic signatures in hESCs, we performed a genome-
wide DNA methylation analysis in undifferentiated or differ-
entiated hESCs with or without EtOH treatment. For these
studies, we again used a 24 hour application of 20 mM EtOH
to allow for comparisons with the results of the genome-wide
transcriptome studies. Examination of DNA methylation
changes that were occurring on the promoters around
transcription start site (TSS) or CpG islands (CGIs) revealed
that EtOH treatment increased global DNA methylation in
undifferentiated hESCs (Figs. 2B and C). Thus, plots of relative
DNA methylation levels at the TSS and the CGIs after
treatment with 20 mM EtOH (left panels) revealed EtOH-
induced DNA hypermethylation at the TSS and the CGIs.
Similarly, aligned probes plot of methylation showed that
treatment of undifferentiated hESCs with 20 mM EtOH
resulted in an increase in DNA methylation compared to non-
treated control (middle panels) and log plots for methylation
comparing control cells (x-axis) vs. cells treated with 20 mM
EtOH (y-axis) also showed greater level of DNA methylation
after EtOH treatment (right panels).
To profile EtOH-induced DNA methylation change on
individual chromosomes, we calculated the average level of
DNA methylation as shown in Fig. 3. We also compared EtOHFigure 2 Global DNA methylation changes at the transcription
(A) EtOH increases DNA methylation in undifferentiated hESCs as m
versus 0 mM EtOH (one-way ANOVA). (B) DNA methylation changes
Relative DNA methylation levels at the TSS (2.5 kb upstream and dow
It shows the status of DNA hypermethylation at the TSS resulted fro
that treatment of undifferentiated hESCs with 20 mM EtOH result
non-treated control (middle). The Log plot for methylation at the T
EtOH (y-axis) showed greater level of DNA methylation after EtOH tr
treatment were assessed as described in (B). Relative DNA methylati
increase in DNA methylation on the DNA sequences upstream of CGIs
with 20 mM EtOH resulted in an increase in DNA methylation at the C
methylation at the CGIs comparing control cells (x-axis) vs. cells t
methylation after EtOH treatment (right).effects on DNA methylation in undifferentiated hESCs versus
EBs. EtOH treatment of undifferentiated hESCs induced
increases in the average levels of DNA methylation in the
promoter regions and CpG islands of each chromosome
(Figs. 3A and B, top row). The level of DNA methylation
changes specific to EtOH treatment in differentiated hESC EBs
was also examined (Figs. 3A and B,middle row). Interestingly,
EtOH had a much smaller effect on DNA methylation in
differentiated EBs. The extent of EtOH's effect on DNA
methylation on each chromosomewas evaluated by calculating
a fold-change in DNA methylation level after EtOH treatment
against untreated controls (Fig. 3, bottom row). Undifferen-
tiated hESCs showed higher fold changes in DNA methylation
upon EtOH treatment than differentiated hESC EBs. We also
found higher fold changes in EtOH-induced DNA methylation in
the promoter regions compared to CGIs. Chromosomes 2, 16
and 18 in undifferentiated hESCs showed the highest increases
in DNA methylation in the promoter regions compared to other
chromosomes.
Although the average level of DNA methylation per
chromosome was increased after EtOH treatment, it does
not mean that all the genes in the chromosome are affected
the same way. To examine the effect of EtOH on the DNA
methylation change in undifferentiated hESCs at the gene
level, we calculated the changes in % of genes that are hyper-
or hypomethylated upon EtOH treatment, after normalizationstart site (TSS) and CpG islands (CGIs) upon EtOH treatment.
easured by changes in % of 5-methylcytosine (5-mC). *p b 0.05
after EtOH treatment in undifferentiated hESCs were assessed.
nstream) after treatment with 20 mM EtOH were plotted (left).
m EtOH treatment. Aligned probes plot of methylation showed
ed in an increase in DNA methylation at the TSS compared to
SS comparing control cells (x-axis) vs. cells treated with 20 mM
eatment (right). (C) DNA methylation changes at CGIs after EtOH
on plot at the CGIs after treatment with 20 mM EtOH showed an
(left). Aligned probes plot of methylation showed that treatment
GIs compared to non-treated control (middle). The Log plot for
reated with 20 mM EtOH (y-axis) showed greater level of DNA
Figure 3 EtOH-induced increases in DNA methylation in undifferentiated hESCs but not in embryoid bodies (EBs). Comparisons of
average relative DNA methylation levels between (A) promoters of genes and (B) CpG islands of genes from undifferentiated hESCs
(top panels) and hESC EBs (middle panels) treated with 0 mM or 20 mM EtOH. Bottom panel shows fold changes in DNA methylation for
promoters and CpG islands of genes in EtOH-treated undifferentiated hESCs (blue bars) and EBs (red bars). Statistical analysis
revealed that the EtOH-induced increases in methylation status of Promoter regions (and to a lesser extent CpG islands) were
significantly different (p b 0.05, unpaired t-test) for undifferentiated hESCs vs. EBs at all 23 chromosomes.
797Molecular effects of alcohol on human embryonic stem cellsagainst untreated cells. Using this type of analysis we
observed that EtOH treatment induced overall increases in
both hyper- and hypomethylation of the promoter regions in
each and all chromosomes (Fig. S2). Interestingly, the % of
genes hyper or hypomethylated by EtOH at the promoter
regions was relatively similar, whereas a much higher % of
genes were hypomethylated at CGIs compared to the % of
hypermethylated genes (Fig. S2). Although this first
appears counterintuitive to the observed global increases inmethylation at promoter regions and CGIs (Figs. 2 & 3), these
data demonstrate that while a greater number of genes were
hypomethylated, the increases in methylation of a smaller
number of genes on individual chromosomes were more than
sufficient to produce overall increases in DNA methylation
status. These data also underscored the differential effect of
EtOH exposure on the methylation of individual hESC genes
and, in turn, suggested likely differential influence of EtOH on
transcriptional regulation of genes on different chromosomes.
798 O. Khalid et al.Molecular correlations between EtOH-induced DNA
methylomic and transcriptomic alterations in hESCs
In order to relate EtOH-induced methylomic alterations
to transcriptional changes we correlated EtOH-induced
methylation changes at the promoter regions (Figs. 4A–C)
and the CpG islands (Figs. 4D–F) to the changes in gene
expression under three conditions: (a) differentiation (Figs. 4A
and D), (b) EtOH treatment of undifferentiated hESCs (Figs. 4B
and E), and (c) EtOH treatment of differentiated EBs (Figs. 4C
and F). Cutoff was made by β value change N0.5 in DNA
methylation and N2-fold in gene expression. From these
correlations, we observed that the majority of expression and
methylation correlations occurred not only during differenti-
ation alone but also following EtOH treatment of both
undifferentiated hESCs and EBs (Fig. 4G).Figure 4 Methylation vs. gene expression in EtOH-treated hESCs
(A) differentiation of hESCs, (B) EtOH treatment of undifferentiate
expression of CpG islands during: (D) differentiation of hESCs, (E) EtO
of EBs. (G) Summary of hyper- and hypomethylated regions and their
EtOH treatment after treatment with 5-azacytidine (5-Aza). Level of
assessed by qRT-PCR analysis with, without EtOH (20 mM), or afte
*p b 0.05 vs. control; **p b 0.05 vs. EtOH treatment (one-way
hypermethylation at 2.5 kb upstream and downstream of the transcr
shown in (B). The genes represent inverse correlation between met
(gold) vs. hypomethylated and upregulated (green). (J) A graph rep
hypomethylated genes and gold represents hypermethylated g
hypermethylation in genes both positively and negatively regulated
a decreased (negative) or increased (positive) gene expression.To determine if EtOH-induced hypermethylation could
account for decreases in gene expression we examined the
effect of 5-azacytidine (1 μM) on the expression level of genes
that were downregulated upon EtOH treatment (Fig. 4H). We
chose four genes (ACADY4, FGF17, HOXA1 and PHOSPHO1) out
of the top ten genes from combined analysis that were
identified as most significantly altered. Co-administration of
EtOH with this demethylating agent overcame the gene
silencing effect of EtOH (Fig. 4H), suggesting that the changes
in the level of these genes are mostly due to DNA methylation
events.
Next, we developed a heatmap to represent the methyla-
tion changes that are occurring at the promoter and intergenic
regions as correlated to expression changes (Fig. 4I). We
observe that these methylation changes are concentrated
around the promoter and transcriptional start site (Fig. 4J) and. Methylation vs. gene expression of promoter regions during:
d hESCs and (C) EtOH treatment of EBs. Methylation vs. gene
H treatment of undifferentiated hESCs, and (F) EtOH treatment
correlation to expression. (H) Rescue of genes downregulated by
ACADY4, FGF17, HOXA1 and PHOSPHO1 genes was quantitatively
r co-treatment with 20 mM EtOH and 1 μM of 5-Aza for 24 h.
ANOVA with Tukey's post hoc). (I) The level of hypo- and
iption start site (TSS) in EtOH-treated undifferentiated hESCs as
hylation and expression — hypermethylated and downregulated
resenting the average methylation found in I (green represents
enes). (K) Pie chart representing the level of hypo- and
. It shows how much hypo- or hypermethylation refers to either
799Molecular effects of alcohol on human embryonic stem cellsare inversely correlated to expression changes (Fig. 4K).
However, there are several changes in methylation that are
not necessarily correlated to changes in gene expression,
suggesting interplay between transcript changes and changes
in DNA methylation status beyond the simple inverse correla-
tion between epigenetics and transcription. This may be due in
part to the fact that genes involved in methyltransferase
activity are changing as observed from our ontological analysis
in Fig. 1F. Thus, EtOH treatment does not only change the
transcriptional profile but also change the epigenetic profile,
which may have more profound implications if these epige-
netic changes are permanent and transmissible.
From the combined data set of EtOH-induced transcriptomic
and DNA methylomic alterations as shown in Fig. 4, we have
further identified a list of genes that are specifically dysregu-
lated by EtOH-induced DNA methylomic changes (Table 1).
Genes that are hypomethylated on CpG islands (or promoter
regions) and upregulated in gene expression and genes
that are hypermethylated on CpG islands (or promoter
regions) and downregulated in gene expression are separately
listed (β value N 0.5 and N2-fold change in expression).Table 1 Differentially regulated genes in undifferentiated hESC
CpGDown P
Gene
symbol
Methyl
(p value)
Expr
(fold)
Gene
symbol
Methyl
(p value)
Expr
(fold)
G
s
IGFBP5 −0.9 3.9 MY05A 0.9 −3.3 A
ADCY10 −0.8 3.7 CXCL2 0.5 −3.2 G
C2CD2L −0.6 3.6 SRC 0.6 −3.2 A
TNPOl −0.6 3.6 SOBP 1.0 −3.2 T
MKRN2 −1.0 3.5 DOCK2 0.6 −2.8 C
IQSEC3 −0.6 3.4 GRHC4 0.5 −2.7 M
SMEK2 −1.0 3.3 AKAP13 0.9 −2.7 M
ALS2CR11 −0.5 3.2 SUZ12P 0.8 −2.7 C
DPP9 −0.6 3.1 SLC38A1 0.5 −2.6 IQ
GIMAP1 −1.0 3.1 SYT7 0.8 −2.6 A
PDPN −0.5 3.1 NCOA3 0.5 −2.6 IL
PPARG −0.9 3.1 WDR60 0.5 −2.5 T
NECAB2 −0.6 3.0 ADAMTS10 0.6 −2.5 S
C8orf46 −0.7 3.0 ITPKB 0.9 −2.5 C
HTR1B −0.7 3.0 EPN1 0.5 −2.5 D
FOXK1 −0.6 2.9 ST8SIA5 0.5 −2.5 G
SDHB −0.5 2.9 GPR39 0.8 −2.4 P
ZNF460 −0.8 2.9 ZAP70 0.9 −2.4 H
PLVAP −0.6 2.9 CD6 0.6 −2.4 P
PTPN21 −0.9 2.7 TTLL1 0.5 −2.4 C
EML2 −0.6 2.7 SMOC2 1.0 −2.4 N
SERP2 −0.6 2.7 PDK4 0.8 −2.3 H
ZPBP2 −0.8 2.7 HOXB3 0.9 −2.3 IL
TFB2M −0.7 2.7 SCAND2 0.6 −2.3 C
KCNJ10 −0.6 2.7 C10orf90 1.0 −2.3 F
GREB1 −0.5 2.6 FNBP4 0.6 −2.3 M
GPR75 −1.0 2.6 CARD 14 0.9 −2.2 S
RAB40AL −0.6 2.6 CCDC93 0.7 −2.2 P
ESR1 −0.9 2.6 SLC25A30 0.6 −2.2 R
RORA −0.51 2.6 NTN3 0.7 −2.2 T
p N 0.5; fold change N 2.EtOH-induced downregulation of stemness markers
Previous studies have shown that even a single exposure
to EtOH during the pre-implantation period enhanced post-
implantation fetal death and resorption and retarded normal
embryo development (Padmanabhan and Hameed, 1988).
Since the pluripotent hESCs are naturally most abundant
during the pre-implantation blastocyst stage we hypothesized
that EtOH exposure might affect their pluripotency, which in
turn would adversely affect their subsequent differentiation.
To address this hypothesis, we first examined the effect of
EtOH on hESC maintenance by immunofluorescence analysis
for stem cell marker proteins. H9 hESCs were treated with
EtOH (20 mM) for 24 h and subjected to IF analysis. The results
showed that the expression of stemness marker proteins
(OCT4, TRA-1-60 and SSEA-3) was visibly reduced with EtOH
treatment (Fig. S3A). Since fetal alcohol exposure is known to
induce programmed cell death in certain embryonic cell
populations (Dunty et al., 2001; Ikonomidou et al., 2000;
Kilburn et al., 2006), we also examined EtOH's effects on the
levels of an early apoptosis marker Annexin V and founds upon EtOH treatment.
romoterUp PromoterDown
ene
ymbol
Methyl
(p value)
Expr
(fold)
Gene
symbol
Methyl
(p value)
Expr
(fold)
POL6 −1.0 4.1 CTU2 0.8 −3.4
USBP1 −0.6 3.7 HBQ1 0.8 −3.3
RHGEF12 −0.8 3.7 MY05A 0.9 −3.3
MEM217 −0.9 3.6 CXCL2 1.0 −3.2
2CD2L −0.5 3.6 SRC 0.6 −3.2
STN −0.6 3.6 SOBP 0.9 −3.2
KRN2 −0.8 3.5 GUCA1C 0.6 −3.0
OL4A5 −0.4 3.5 LILRB1 0.6 −2.9
SEC3 −0.6 3.4 MAGEA11 0.9 −2.8
LS2CR11 −0.6 3.2 GRIK4 0.6 −2.7
12B −0.6 3.2 ASB15 0.6 −2.7
ACR1 −0.6 3.1 SUZ12P 1.0 −2.7
LC25A4 −0.7 3.1 SYT7 0.6 −2.6
CDC140 −0.7 3.1 UBE2D3 1.0 −2.6
PP9 −0.9 3.1 PTPN22 1.0 −2.5
IMAP1 −0.6 3.1 ITPKB 0.9 −2.5
DPN −0.6 3.1 GRIA3 0.6 −2.4
AL −0.9 3.1 ATP8B4 0.6 −2.4
PARG −0.9 3.1 NEU2 0.9 −2.4
D96 −0.6 3.1 RAB3IP 0.8 −2.4
ECAB2 −0.7 3.0 PSCA 0.5 −2.3
TR1B −0.7 3.0 ARHGEF11 0.6 −2.3
2 −0.6 3.0 SAR1B 0.7 −2.3
RB1 −0.6 2.9 RAD21L1 0.9 −2.3
OXK1 −0.7 2.9 FNBP4 0.8 −2.3
IA2 −0.6 2.9 DCAF6 0.8 −2.2
DHB −0.7 2.9 SLC6A4 0.8 −2.2
LYAP −0.6 2.9 CCDC80 1.0 −2.2
EPIN 1 −0.5 2.8 CCDC93 0.9 −2.2
EX11 −0.7 2.8 OMD 0.6 −2.2
800 O. Khalid et al.noticeable increases in Annexin V immunoreactivity in hESCs
after 20 mM EtOH treatment (Fig. S3A). Based on these
immunohistochemical data, we next examined EtOH's effects
on the expression of 6 stemness marker genes by quantitative
RT-PCR (Fig. S3A). Treatment with EtOH (20 or 50 mM)
resulted in significant downregulation of DNMT3B, NANOG,
OCT4 and SOX2, with the remaining FOXD3 and TERT also
showing a trend of decreased expression (Fig. S3B). We then
reasoned that if pluripotency markers that maintain self-
renewing hESCs were downregulated by EtOH, this is likely to
have significant effects on the regulation of “downstream”
differentiation markers. Analysis of qRT-PCR data for a set of
previously described differentiationmarkers representative of
the mesoderm (BRACHYURY, HAND1, MEOX1), definitive and
primitive endoderm (CDX2, EOMES, GATA4, GATA6, SOX7,
SOX17, TBX6) and ectoderm (NESTIN, PAX6), respectively (Teo
et al., 2011) revealed significant up- or down-regulation of 9
out of these 12markers with EtOH treatment (Fig. S3C). Based
on the above data and the profound effects of EtOH exposure
during the blastocyst stage on subsequent embryo develop-
ment and viability (Padmanabhan and Hameed, 1988), we
next focused on the effect of EtOH on differentiation-related
gene expression in hESCs. To identify specific genes that
may be affected by EtOH during differentiation of hESCs,
genes that are differentially regulated during EB formation
were compared to genes differentially regulated upon EtOH
treatment in undifferentiated hESCs (Fig. 5). From this
analysis we have identified a subset of genes significantlyFigure 5 Profiling of molecular signatures specifically affected by
that are epigenetically altered by EtOH-induced DNA methylation cha
in gene expression were identified. Genes showing β N 0.5 in DNA me
change in gene expression were chosen from Fig. 4. Comparison wa
hESCs. By combining the list of genes differentially regulated during
treatment in undifferentiated hESCs, we were able to identify gene
EtOH-induced DNA methylation changes (common genes).altered by EtOH treatment that are potentially involved in
differentiation of hESCs into EBs (orange box, Fig. 5). Due to
the figure size limitations, only the top 10 genes are illustrated
in each panel. The complete list of genes for each panel is
shown in the Supplemental Table 1.Validation of genes differentially regulated by EtOH-
induced DNA methylation changes
We next validated genes identified from the combined
analysis. Based on the observed decreases in stemnessmarkers
(Fig. S3), we continued to focus on molecular signatures
affected by EtOH-induced DNA methylation changes that may
have significant roles in stem cell maintenance and differen-
tiation process. Therefore, we examined EtOH's effect on the
subset of genes that are potentially differentiation-related as
shown in Fig. 5. DAVID analysis on the identified top 30 genes
was performed to examine their functional implication. We
found that these genes were mostly associated with neuroac-
tive ligand–receptor interaction, vascular smooth muscle
contraction, calcium signaling pathways, and energy metab-
olism. Energy metabolism and its associated pathways are
considered to be important cellular processes in maintaining
stem cell self-renewal and potency (Cho et al., 2006; Rafalski
et al., 2012; Ramm Sander et al., 2013). For validation, the
levels of mRNA for selected genes were assessed by qRT-PCR
analysis (Fig. 6). Even though we relied on GAPDH as a singleEtOH-induced DNA methylation in hESCs. To obtain a list of genes
nges, genes showing correlative changes in DNA methylation and
thylation either on CpG islands or promoter regions with N2-fold
s done to examine the effect of EtOH on the differentiation of
hESC differentiation and the list of genes dysregulated by EtOH
s that are potentially involved in the differentiation of hESC by
Figure 6 Quantitative RT-PCR validation of gene list. The
expression levels of part of genes list obtained from Fig. 5 were
validated. hESCs were treated with 0, 20, or 50 mM EtOH for 24 h
and qRT-PCR performed as described in Material and Methods.
(A) Genes that were upregulated by EtOH-induced DNA hypome-
thylation. Note significantly increased expression in 3 of 8 genes,
with none significantly decreased. (B) Genes that were down-
regulated by EtOH-induced hypermethylation. Note significantly
decreased expression in 4 of 8 genes, with none significantly
increased. Bars are mean ± SEM from triplicates; *p b 0.05 vs.
control; †p b 0.05 vs. 20 mM EtOH (one-way ANOVA with Tukey
post hoc).
801Molecular effects of alcohol on human embryonic stem cellsreference gene (Carnahan et al., 2013), we found that most of
the genes in our experimental set (subset of EtOH-induced
differentiation related genes with promotermethylation in the
middle panel of Fig. 5) were definitively validated. C2CD2L,
GUSBP1 and TMEM217 were significantly upregulated and
demonstrated concentration dependency to EtOH treatment
(Fig. 6A). By contrast, P2RX3, PIK3C3, SLC12A4 and SLC25A30
were significantly downregulated (Fig. 6B). Thus, most of the
genes subjected to qRT-PCR analysis showed the expected
trends of gene expression. Of the downregulated genes,SLC12A4 is involved in K–Cl transport and participates in
cell volume homeostasis and cholesterol metabolism (Adragna
et al., 2004; Zhou et al., 2004). The gene is localized to
chromosome 16, which we identified as one of the hotspots,
(see Fig. 3). P2RX3 codes for a ligand-gated cation channel,
which is involved in responses to extracellular ATP, cation
transport, Ca-mediated signal transduction, and behavioral
responses to pain (Burnstock, 2007). However, the specific
functional role of these genes in EtOH-induced hESC self-
renewal and potency remains to be investigated.Commonmotif analysis and EtOH-related transcription
factor discovery
Subsequently, we studied whether there was any
sequence specificity to the genes that were being affected
by EtOH treatment (Fig. 7). From the genes that are
significantly affected by EtOH (shown in yellow Venn-
diagram), we wanted to find a subset of genes that is also
related to differentiation (shown in purple Venn-diagram).
The common genes between genes affected by EtOH treat-
ment and genes altered during differentiation represent genes
that may be involved in differentiation profile due to EtOH
treatment (middle in Venn-diagram). The common genes were
found in all four conditions, CpG and promoter; as well as
increased expression (upregulated) and decreased expression
(downregulated). To examine if these common genes affected
by EtOH share any sequence motifs for transcription factors,
we have performed motif analysis using the regulatory
sequence analysis tool (RSAT) (Thomas-Chollier et al., 2012).
We discovered two major motifs represented within the genes
that are commonly associated with differentiation of hESCs
and also EtOH exposure. Thus, these motifs may represent
potential binding sites of transcription factors that may play a
role in differentiation changes that are occurring in hESCs
upon exposure to EtOH. Furthermore, these motifs may be
used as predictive signatures for genes affected by EtOH
treatment. We used the Similarity, Tree-building, and
Alignment of DNA Motifs and Profiles (STAMP) motif analysis
tool (Mahony and Benos, 2007) to determine what transcrip-
tion factors could be involved in this process (Fig. 7) (Mahony
and Benos, 2007). The most significant motifs and associated
transcriptional factors that are correlated to EtOH treatment
are shown (Fig. 7). Putting together individual module motif
and transcription factor analysis, we found transcription
factors well known in stem cell maintenance/differentiation
such as the FOX, SMAD and POU family to be implicated, as
well as transcription factors involved in hepatogenesis,
suggesting alteration of differentiation in the hepatic lineage.
Furthermore we performed a consensus analysis to examine
possible involvement of these transcription factors in EtOH-
induced molecular alterations in hESCs. We compared those
genes altered by EtOH treatment against genes altered in
hESCs treated with short hairpin RNA targeting OCT4 (shOCT4,
obtained from publicly available data sets, GEO accession
number: GSE34921). We found the significant modules of
alterations specifically associatedwith the stemness transcrip-
tion factor and EtOH treatment (Fig. S4). This further suggests
that EtOH treatment in hESCs can lead to fundamental
alterations in the regulatory network of transcription factors
involved in stemness and lineage commitment (Fig. S4).
Figure 7 Common motif analysis and EtOH-related transcription factor discovery. Genes that are affected by normal
differentiation are shown in purple Venn diagrams (Up_Diff: Hypomethylated and upregulated during differentiation; Down_Diff:
Hypermethylated and downregulated during differentiation). Genes that are significantly affected by EtOH are shown in yellow Venn
diagrams (Up_EtOH: Hypomethylated and upregulated upon EtOH treatment; Down_EtOH: Hypermethylated and downregulated upon
EtOH treatment). Subsets of genes that are affected by both EtOH and differentiation are shown in the middle. These genes are also
represented in the middle orange box of Fig. 5. Selected genes were further subjected to STAMP analysis to identify potential
cis-regulatory elements that are present in the differentially regulated genes and transcription factors that could be potentially
affected by EtOH treatment. Based on the common gene lists, common motifs and associated transcriptional factors are found for
CpG and promoter respectively. E-value is calculated based on the Wasserman and Sandelin method (Wasserman and Sandelin, 2004).
802 O. Khalid et al.DiscussionThe effect of alcohol on development has been extensively
studied in many different animal species (Cudd, 2005).
In particular, a single exposure to EtOH during the pre-
implantation period was shown to enhance post-implantation
fetal death and resorption and to retard normal embryo
development (Padmanabhan and Hameed, 1988). In humans,
fetal alcohol exposure (FAE) is also correlated with low birth
weight, growth, and morphological abnormalities (Day et al.,
1989), and in higher rates of spontaneous abortions (Kline
et al., 1980; Windham et al., 1997). Numerous other reports
have demonstrated genetic, cellular, and biochemical associ-
ation of alcohol with teratogenesis (Armant and Saunders,
1996; Goodlett and Horn, 2001; Resnicoff et al., 1994; Wozniak
et al., 2004). Thewide range of physiological andmorphological
defects associated with FAE suggests that the etiology of FASDs
involves a high degree of cellular and molecular heterogeneity.
The gastrulation period is considered to be the most sensitive
to teratogenic insult, suggesting that differentiating cells
might be especially vulnerable to the teratogenic effects of
EtOH (Armant and Saunders, 1996).
Here we examined the effect of EtOH on the pluripotency
of undifferentiated hESCs as amodel of early FAE that includes
the pre-implantation period. Specifically, we demonstrated
that a 24 hour low dose (20 mM) EtOH treatment significantly
reduced the pluripotency (differentiation potential) of hESCs.
While to our knowledge no other hESC studies have addressedthis issue, somewhat analogous observations were made with
rhesus monkey ESCs, albeit at much higher EtOH concentra-
tions and over a course of 4 weeks (VandeVoort et al., 2011).
We also, for the first time, demonstrated overall increases in
DNA methylation in hESCs, defined the genetic and epigenetic
molecular landscapes affected by low dose EtOH exposure,
and identified genome-wide hotspots that could potentially be
vulnerable to FAE. Furthermore, we have identified land-
scapes of molecular networks that are potentially deregulated
by EtOH exposure through DNA methylomic alterations. This is
in contrast to the recently reported lack ofmethylation changes
after exposure of hESCs to 20 mM EtOH (Krishnamoorthy et al.,
2013). Interestingly, their reported selective gene subsets are,
for the most part, also unchanged in our study, whereas the
much larger set of genes which do show methylation changes
in our study are not reported by these authors. Furthermore,
numerous studies have linked epigenetic mechanisms as
potential regulatory events involved in alcohol teratogenesis
(Bielawski et al., 2002; Garro et al., 1991; Haycock, 2009;
Kaminen-Ahola et al., 2010). Epigenetic imprinting or genome-
wide epigenetic reprogramming has been proposed as a
mechanism responsible for alcohol-induced teratogenesis in
preimplantation embryos (Haycock, 2009; Haycock and
Ramsay, 2009). Interestingly, even paternal or maternal alcohol
consumption prior to conception has been shown to result in a
wide range of birth defects and fetal abnormalities. It is likely
that alcohol-induced epigenetic changes in the gametes or
within germ line are responsible for pre-conceptional effects of
alcohol (Abel, 2004).
803Molecular effects of alcohol on human embryonic stem cellsWe observed numerous instances where EtOH had a
differential effect on the transcriptome and methylome of
undifferentiated hESCs compared to EBs, which contain
differentiating cells encompassing all somatic cell types
(Itskovitz-Eldor et al., 2000) including those of neural and
hepatic cell lineages. Recent studies have demonstrated
inhibitory effects of pharmacologically relevant EtOH con-
centrations (20–100 mM) on neuronal differentiation of ESCs
and specified neural stem cells (NSCs). Specifically, EtOH
was shown to inhibit NSC proliferation with dose-dependent
increases in apoptosis (Anthony et al., 2008; Fujita et al., 2008;
Talens-Visconti et al., 2011), decrease NSC differentiation
(Tateno et al., 2004; Zhou et al., 2011) and divert ESC
differentiation from neuroectodermal to mesodermal lineage
(Ogony et al., 2013; Sanchez-Alvarez et al., 2013). Others
utilizing very high EtOH concentrations (300–2000 mM) also
observed increased apoptosis of mouse blastocysts (Huang et
al., 2007) and increased endodermal differentiation of EBs
(Mayshar et al., 2011). Another recent study that focused on
differentiation of human hepatocytes from EBs demonstrated
that a 48 hour EtOH (20 mM) treatment perturbed the
differentiation of progenitor cells into hepatocytes (Pal et al.,
2012). Given our focus on the early onset of hESC differentiation
(2–3 days) versus their longer than 21 days of differentiation,
direct comparisons are difficult, nevertheless commonalities
include EtOH-induced downregulation of the stem cell tran-
scription marker, OCT4, and downregulation of several differ-
entiation markers associated with the formation of definitive
endoderm and functional hepatocytes (GATA6 and SOX17, see
Fig. S3). In addition, we used WCGNA to demonstrate many
similarities between selective OCT4 knockdown (Wang et al.,
2012) and EtOH effects on undifferentiated hESCs (Fig. S4).
Overall, published literature supports our findings of a selective
impact of EtOH on differentiating cells compared to undiffer-
entiated stem cells.
Our methylome profiling revealed hotspots of DNA methyl-
ation on chromosomes 2, 16 and 18. Association of these
chromosomes with alcohol dependence has been reported
(Dick et al., 2010; Foroud et al., 1998; Treutlein et al., 2009;
Wang et al., 2005). Thus, using earlier findings that chromo-
some 2, especially 2p14-2q14.3, is associated with phenotypes
of alcohol dependence, suicide attempts, and conduct
disorder, a systematic screen of SNPs with the three comorbid
phenotypes yielded evidence of association with 23 genes,
likely contributing to the preponderance of reported linkages
with alcohol dependence and related phenotypes across
chromosome 2 (Dick et al., 2010). Another study utilized a
genome-wide association study, discovering 15 SNPs signifi-
cantly associated with the same allele that had shown
expression changes in rat brains after long-term alcohol
consumption. In the combined analysis, 2 closely linked
intergenic SNPs are located on chromosome region 2q35,
which has been implicated in linkage studies for alcohol
phenotypes, including the CDH13 and ADH1C genes that have
been reported to be associated with alcohol dependence
(Treutlein et al., 2009). Linkage analysis also detected loci
underlying moderate and severe alcoholism implicating chro-
mosome 16 (Foroud et al., 1998). In other studies, patients
with carcinoid tumors had frequent history of alcohol
consumption (Wang et al., 2005). Allelic loss of chromosome
11qwas present in 21% of tumors, chromosome 16q in 13%, and
chromosome 18 in 30% (Wang et al., 2005).In addition to identifying EtOH-induced global changes in
genetic and epigenetic molecular landscapes, wewere able to
narrow down these changes further to four major potential
signaling pathways with the help of extensive bioinformatic
analyses. To our knowledge, this is the first time that energy
metabolism, neuroactive ligand–receptor interaction, vascu-
lar smooth muscle contraction, and calcium signaling path-
ways are implicated in EtOH-induced changes in human
embryonic stem cells. We provided strong molecular and
bioinformatic evidence that even at a low physiologically
relevant dose, EtOH may epigenetically alter key genes such
as SLC12A4, P2RX3 and others in glycerophospholipid metab-
olism and regulation of calcium ion transport and/or calcium-
mediated signaling, which ultimately may lead to the
significant decrease in the self-renewal capacity of hESCs.
Scientific findings presented in this report provide us with
novel opportunities that have yet to be explored. Elucidating
epigenetic molecular signatures and pathways affected by
ethanol will significantly advance our understanding of the
mechanisms of ethanol's effect on human stem cells. More-
over, defining the molecular changes that occur in our stem
cell model systems can potentially be used to for designing
future clinical applications of stem cells to improve human
health.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.03.009.Contribution statement
O.K., J.J.K. and Y.K. participated in designing the experiments,
execution of described works, statistical analysis, interpreta-
tion of data and writing the manuscript.
H.-S.K., M.H., O.E., C.L., C.V. and T.T. contributed to
the execution of the experiments or writing the manuscript.
S.H. provided statistical consultation and bioinformatic
support.
I.S. participated in the interpretation of data and writing
the manuscript.Acknowledgments
We thank the UCLA Clinical Microarray Core Facility for microarray
analysis. We also acknowledge the UCLA Broad Stem Cell Institute
for providing us with human embryonic stem cell cultures. This work
was supported by an NIH award from NIAAA (R01AA21301), CIRM
Basic Biology Award II (RB02-1562), and UCLA School of Dentistry
Faculty Seed Grant Award to Y.K. and T32 training grant awards
from NIDCR to O.K. and J.J.K. (T32DE07269).
References
Abel, E., 2004. Paternal contribution to fetal alcohol syndrome.
Addict. Biol. 9, 127–133 (discussion 135–126).
Adragna, N.C., Di Fulvio, M., Lauf, P.K., 2004. Regulation of K–Cl
cotransport: from function to genes. J. Membr. Biol. 201, 109–137.
Anthony, B., Zhou, F.C., Ogawa, T., Goodlett, C.R., Ruiz, J., 2008.
Alcohol exposure alters cell cycle and apoptotic events during
early neurulation. Alcohol Alcohol. 43, 261–273.
Armant, D.R., Saunders, D.E., 1996. Exposure of embryonic cells to
alcohol: contrasting effects during preimplantation and postim-
plantation development. Semin. Perinatol. 20, 127–139.
804 O. Khalid et al.Bartolomei, M.S., 2003. Epigenetics: role of germ cell imprinting.
Adv. Exp. Med. Biol. 518, 239–245.
Bedford, D., O'Farrell, A., Howell, F., 2006. Blood alcohol levels in
persons who died from accidents and suicide. Ir. Med. J. 99,
80–83.
Bielawski, D.M., Zaher, F.M., Svinarich, D.M., Abel, E.L., 2002.
Paternal alcohol exposure affects sperm cytosinemethyltransferase
messenger RNA levels. Alcohol. Clin. Exp. Res. 26, 347–351.
Brien, J.F., Loomis, C.W., Tranmer, J., McGrath, M., 1983. Disposition
of ethanol in human maternal venous blood and amniotic fluid.
Am. J. Obstet. Gynecol. 146, 181–186.
Burnstock, G., 2007. Purine and pyrimidine receptors. Cell. Mol. Life
Sci. 64, 1471–1483.
Carnahan, M.N., Veazey, K.J., Muller, D., Tingling, J.D., Miranda, R.
C., Golding, M.C., 2013. Identification of cell-specific patterns
of reference gene stability in quantitative reverse-transcriptase
polymerase chain reaction studies of embryonic, placental and
neural stem models of prenatal ethanol exposure. Alcohol 47,
109–120.
Cavalli, G., 2006. Chromatin and epigenetics in development:
blending cellular memory with cell fate plasticity. Development
(Cambridge, England) 133, 2089–2094.
Cho, Y.M., Kwon, S., Pak, Y.K., Seol, H.W., Choi, Y.M., Park do, J.,
Park, K.S., Lee, H.K., 2006. Dynamic changes in mitochondrial
biogenesis and antioxidant enzymes during the spontaneous
differentiation of human embryonic stem cells. Biochem. Biophys.
Res. Commun. 348, 1472–1478.
Crews, F.T., Nixon, K., 2003. Alcohol, neural stem cells, and adult
neurogenesis. Alcohol. Res. Health 27, 197–204.
Crews, F.T., Miller, M.W., Ma, W., Nixon, K., Zawada, W.M.,
Zakhari, S., 2003. Neural stem cells and alcohol. Alcohol. Clin.
Exp. Res. 27, 324–335.
Cudd, T.A., 2005. Animal model systems for the study of alcohol
teratology. Exp. Biol. Med. (Maywood) 230, 389–393.
Day, N.L., Jasperse, D., Richardson, G., Robles, N., Sambamoorthi, U.,
Taylor, P., Scher, M., Stoffer, D., Cornelius, M., 1989. Prenatal
exposure to alcohol: effect on infant growth and morphologic
characteristics. Pediatrics 84, 536–541.
Dick, D.M., Meyers, J., Aliev, F., Nurnberger Jr., J., Kramer, J.,
Kuperman, S., Porjesz, B., Tischfield, J., Edenberg, H.J., Foroud,
T., et al., 2010. Evidence for genes on chromosome 2 contributing
to alcohol dependence with conduct disorder and suicide
attempts. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B,
1179–1188.
Dunty Jr., W.C., Chen, S.Y., Zucker, R.M., Dehart, D.B., Sulik, K.K.,
2001. Selective vulnerability of embryonic cell populations to
ethanol-induced apoptosis: implications for alcohol-related birth
defects and neurodevelopmental disorder. Alcohol. Clin. Exp.
Res. 25, 1523–1535.
Floyd, R.L., O'Connor, M.J., Sokol, R.J., Bertrand, J., Cordero, J.F.,
2005. Recognition and prevention of fetal alcohol syndrome.
Obstet. Gynecol. 106, 1059–1064.
Floyd, R.L., Weber, M.K., Denny, C., O'Connor, M.J., 2009.
Prevention of fetal alcohol spectrum disorders. Dev. Disabil.
Res. Rev. 15, 193–199.
Foroud, T., Bucholz, K.K., Edenberg, H.J., Goate, A., Neuman, R.J.,
Porjesz, B., Koller, D.L., Rice, J., Reich, T., Bierut, L.J., et al.,
1998. Linkage of an alcoholism-related severity phenotype to
chromosome 16. Alcohol. Clin. Exp. Res. 22, 2035–2042.
French, M.T., Zavala, S.K., 2007. The health benefits of moderate
drinking revisited: alcohol use and self-reported health status.
Am. J. Health Promot. 21, 484–491.
Fujita, Y., Hiroyama, M., Sanbe, A., Yamauchi, J., Murase, S.,
Tanoue, A., 2008. ETOH inhibits embryonic neural stem/
precursor cell proliferation via PLD signaling. Biochem. Biophys.
Res. Commun. 370, 169–173.
Garic, A., Flentke, G.R., Amberger, E., Hernandez, M., Smith, S.M.,
2011. CaMKII activation is a novel effector of alcohol'sneurotoxicity in neural crest stem/progenitor cells. J.
Neurochem. 118, 646–657.
Garro, A.J., McBeth, D.L., Lima, V., Lieber, C.S., 1991. Ethanol
consumption inhibits fetal DNA methylation in mice: implications
for the fetal alcohol syndrome. Alcohol. Clin. Exp. Res. 15,
395–398.
Goodlett, C.R., Horn, K.H., 2001. Mechanisms of alcohol-induced
damage to the developing nervous system. Alcohol. Res. Health
25, 175–184.
Gunzerath, L., Faden, V., Zakhari, S., Warren, K., 2004. National
Institute on Alcohol Abuse and Alcoholism report on moderate
drinking. Alcohol. Clin. Exp. Res. 28, 829–847.
Haycock, P.C., 2009. Fetal alcohol spectrum disorders: the
epigenetic perspective. Biol. Reprod. 81, 607–617.
Haycock, P.C., Ramsay, M., 2009. Exposure of mouse embryos to
ethanol during preimplantation development: effect on DNA
methylation in the h19 imprinting control region. Biol. Reprod.
81, 618–627.
Hoyme, H.E., May, P.A., Kalberg, W.O., Kodituwakku, P., Gossage,
J.P., Trujillo, P.M., Buckley, D.G., Miller, J.H., Aragon, A.S.,
Khaole, N., et al., 2005. A practical clinical approach to
diagnosis of fetal alcohol spectrum disorders: clarification of
the 1996 Institute of Medicine criteria. Pediatrics 115, 39–47.
Huang da, W., Sherman, B.T., Lempicki, R.A., 2009. Systematic and
integrative analysis of large gene lists using DAVID bioinformatics
resources. Nat. Protoc. 4, 44–57.
Huang, L.H., Shiao, N.H., Hsuuw, Y.D., Chan, W.H., 2007.
Protective effects of resveratrol on ethanol-induced apoptosis
in embryonic stem cells and disruption of embryonic develop-
ment in mouse blastocysts. Toxicology 242, 109–122.
Ikonomidou, C., Bittigau, P., Ishimaru, M.J., Wozniak, D.F., Koch, C.,
Genz, K., Price, M.T., Stefovska, V., Horster, F., Tenkova, T., et
al., 2000. Ethanol-induced apoptotic neurodegeneration and fetal
alcohol syndrome. Science 287, 1056–1060.
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka,
O., Amit, M., Soreq, H., Benvenisty, N., 2000. Differentiation of
human embryonic stem cells into embryoid bodies compromising
the three embryonic germ layers. Mol. Med. 6, 88–95.
Jones, A.W., Sternebring, B., 1992. Kinetics of ethanol and methanol
in alcoholics during detoxification. Alcohol Alcohol. 27, 641–647.
Kafri, T., Ariel, M., Brandeis, M., Shemer, R., Urven, L., McCarrey,
J., Cedar, H., Razin, A., 1992. Developmental pattern of gene-
specific DNA methylation in the mouse embryo and germ line.
Genes Dev. 6, 705–714.
Kaminen-Ahola, N., Ahola, A., Maga, M., Mallitt, K.-A., Fahey, P.,
Cox, T.C., Whitelaw, E., Chong, S., 2010. Maternal ethanol
consumption alters the epigenotype and the phenotype of
offspring in a mouse model. PLoS Genet. 6, e1000811.
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., Tanabe, M., 2012.
KEGG for integration and interpretation of large-scale molecular
data sets. Nucleic Acids Res. 40, D109–D114.
Kiefer, J.C., 2007. Epigenetics in development. Dev. Dyn. 236,
1144–1156.
Kilburn, B.A., Chiang, P.J., Wang, J., Flentke, G.R., Smith, S.M.,
Armant, D.R., 2006. Rapid induction of apoptosis in gastrulating
mouse embryos by ethanol and its prevention by HB-EGF.
Alcohol. Clin. Exp. Res. 30, 127–134.
Kleiber, M.L., Laufer, B.I., Wright, E., Diehl, E.J., Singh, S.M., 2012.
Long-term alterations to the brain transcriptome in a maternal
voluntary consumption model of fetal alcohol spectrum disor-
ders. Brain Res. 1458, 18–33.
Kline, J., Shrout, P., Stein, Z., Susser, M., Warburton, D., 1980. Drinking
during pregnancy and spontaneous abortion. Lancet 2, 176–180.
Kondo, T., 2006. Epigenetic alchemy for cell fate conversion. Curr.
Opin. Genet. Dev. 16, 502–507.
Krishnamoorthy, M., Gerwe, B.A., Scharer, C.D., Sahasranaman, V.,
Eilertson, C.D., Nash, R.J., Usta, S.N., Kelly, S., Rose, M.,
Peraza, R., et al., 2013. Ethanol alters proliferation and
805Molecular effects of alcohol on human embryonic stem cellsdifferentiation of normal and chromosomally abnormal human
embryonic stem cell-derived neurospheres. Birth Defects Res. B
Dev. Reprod. Toxicol. 98, 283–295.
Krzywinski, M., Birol, I., Jones, S.J., Marra, M.A., 2012. Hive plots —
rational approach to visualizing networks. Brief. Bioinform. 13,
627–644.
Langfelder, P., Horvath, S., 2008. WGCNA: an R package for
weighted correlation network analysis. BMC Bioinforma. 9, 559.
Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-
Rohani, H., Amann, M., Anderson, H.R., Andrews, K.G., Aryee,
M., et al., 2012. A comparative risk assessment of burden of
disease and injury attributable to 67 risk factors and risk factor
clusters in 21 regions, 1990–2010: a systematic analysis for the
Global Burden of Disease Study 2010. Lancet 380, 2224–2260.
Luo, J., 2009. GSK3beta in ethanol neurotoxicity. Mol. Neurobiol.
40, 108–121.
Mahony, S., Benos, P.V., 2007. STAMP: a web tool for exploring DNA-
binding motif similarities. Nucleic Acids Res. 35, W253–W258.
Mahony, S., Auron, P.E., Benos, P.V., 2007. DNA familial binding
profiles made easy: comparison of various motif alignment and
clustering strategies. PLoS Comput. Biol. 3, e61.
May, P.A., Gossage, J.P., Kalberg, W.O., Robinson, L.K., Buckley, D.,
Manning, M., Hoyme, H.E., 2009. Prevalence and epidemiologic
characteristics of FASD from various research methods with an
emphasis on recent in-school studies. Dev. Disabil. Res. Rev. 15,
176–192.
Mayshar, Y., Yanuka, O., Benvenisty, N., 2011. Teratogen screening
using transcriptome profiling of differentiating human embryon-
ic stem cells. J. Cell. Mol. Med. 15, 1393–1401.
Miranda, R.C., 2012. MicroRNAs and fetal brain development:
implications for ethanol teratology during the second trimester
period of neurogenesis. Front. Genet. 3, 77.
Nash, R., Krishnamoorthy, M., Jenkins, A., Csete, M., 2012. Human
embryonic stem cell model of ethanol-mediated early develop-
mental toxicity. Exp. Neurol. 234, 127–135.
Nava-Ocampo, A.A., Velazquez-Armenta, Y., Brien, J.F., Koren, G.,
2004. Elimination kinetics of ethanol in pregnant women. Reprod.
Toxicol. 18, 613–617.
Nixon, K., Morris, S.A., Liput, D.J., Kelso, M.L., 2010. Roles of
neural stem cells and adult neurogenesis in adolescent alcohol
use disorders. Alcohol 44, 39–56.
Ogony, J.W., Malahias, E., Vadigepalli, R., Anni, H., 2013. Ethanol
alters the balance of Sox2, Oct4, and Nanog expression in
distinct subpopulations during differentiation of embryonic stem
cells. Stem Cells Dev. 22, 2196–2210.
Padmanabhan, R., Hameed, M.S., 1988. Effects of acute doses of
ethanol administered at pre-implantation stages on fetal
development in the mouse. Drug Alcohol Depend. 22, 91–100.
Pal, R., Mamidi, M.K., Das, A.K., Gupta, P.K., Bhonde, R., 2012. A
simple and economical route to generate functional hepatocyte-
like cells from hESCs and their application in evaluating alcohol
induced liver damage. J. Cell. Biochem. 113, 19–30.
Palmer, J.A., Poenitzsch, A.M., Smith, S.M., Conard, K.R., West, P.
R., Cezar, G.G., 2012. Metabolic biomarkers of prenatal alcohol
exposure in human embryonic stem cell-derived neural lineages.
Alcohol. Clin. Exp. Res. 36 (8), 1314–1324.
Pikkarainen, P.H., 1971. Metabolism of ethanol and acetaldehyde in
perfused human fetal liver. Life Sci. II 10, 1359–1364.
Rafalski, V.A., Mancini, E., Brunet, A., 2012. Energy metabolism and
energy-sensing pathways in mammalian embryonic and adult
stem cell fate. J. Cell Sci. 125, 5597–5608.
Ramm Sander, P., Hau, P., Koch, S., Schutze, K., Bogdahn, U.,
Kalbitzer, H.R., Aigner, L., 2013. Stem cell metabolic and
spectroscopic profiling. Trends Biotechnol. 31, 204–213.
Ramsay, M., 2010. Genetic and epigenetic insights into fetal alcohol
spectrum disorders. Genome Med. 2, 27.
Resnicoff, M., Rubini, M., Baserga, R., Rubin, R., 1994. Ethanol
inhibits insulin-like growth factor-1-mediated signalling andproliferation of C6 rat glioblastoma cells. Lab. Investig. 71,
657–662.
Riley, E.P., Infante, M.A., Warren, K.R., 2011. Fetal alcohol
spectrum disorders: an overview. Neuropsychol. Rev. 21, 73–80.
Roitbak, T., Thomas, K., Martin, A., Allan, A., Cunningham, L.A.,
2011. Moderate fetal alcohol exposure impairs neurogenic capacity
of murine neural stem cells isolated from the adult subventricular
zone. Exp. Neurol. 229, 522–525.
Sanchez-Alvarez, R., Gayen, S., Vadigepalli, R., Anni, H., 2013.
Ethanol diverts early neuronal differentiation trajectory of
embryonic stem cells by disrupting the balance of lineage
specifiers. PLoS One 8, e63794.
Shankar, K., Ronis, M.J., Badger, T.M., 2007. Effects of pregnancy
and nutritional status on alcohol metabolism. Alcohol. Res.
Health 30, 55–59.
Sonne, S., Shekhawat, P.S., Matern, D., Ganapathy, V., Ignatowicz,
L., 2012. Carnitine deficiency in OCTN2−/− newborn mice leads
to a severe gut and immune phenotype with widespread atrophy,
apoptosis and a pro-inflammatory response. PLoS One 7, e47729.
Steiber, A., Kerner, J., Hoppel, C.L., 2004. Carnitine: a nutritional,
biosynthetic, and functional perspective. Mol. Aspects Med. 25,
455–473.
Surani, M.A., Hayashi, K., Hajkova, P., 2007. Genetic and epigenetic
regulators of pluripotency. Cell 128, 747–762.
Talens-Visconti, R., Sanchez-Vera, I., Kostic, J., Perez-Arago, M.A.,
Erceg, S., Stojkovic, M., Guerri, C., 2011. Neural differentiation
from human embryonic stem cells as a tool to study early brain
development and the neuroteratogenic effects of ethanol. Stem
Cells Dev. 20, 327–339.
Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M.,
Sai, Y., Tsuji, A., 1998. Molecular and functional identification
of sodium ion-dependent, high affinity human carnitine trans-
porter OCTN2. J. Biol. Chem. 273, 20378–20382.
Tateno, M., Ukai, W., Ozawa, H., Yamamoto, M., Toki, S., Ikeda, H.,
Saito, T., 2004. Ethanol inhibition of neural stem cell differen-
tiation is reduced by neurotrophic factors. Alcohol. Clin. Exp.
Res. 28, 134S–138S.
Teo, A.K., Arnold, S.J., Trotter, M.W., Brown, S., Ang, L.T., Chng,
Z., Robertson, E.J., Dunn, N.R., Vallier, L., 2011. Pluripotency
factors regulate definitive endoderm specification through
eomesodermin. Genes Dev. 25, 238–250.
Thomas, J.D., Riley, E.P., 1998. Fetal alcohol syndrome: does alcohol
withdrawal play a role? Alcohol. Health Res. World 22, 47–53.
Thomas-Chollier, M., Herrmann, C., Defrance, M., Sand, O.,
Thieffry, D., van Helden, J., 2012. RSAT peak-motifs: motif
analysis in full-size ChIP-seq datasets. Nucleic Acids Res. 40, e31.
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A.,
Swiergiel, J.J., Marshall, V.S., Jones, J.M., 1998. Embryonic stem
cell lines derived from human blastocysts. Science 282, 1145–1147.
Treutlein, J., Cichon, S., Ridinger, M., Wodarz, N., Soyka, M., Zill, P.,
Maier, W., Moessner, R., Gaebel, W., Dahmen, N., et al., 2009.
Genome-wide association study of alcohol dependence. Arch. Gen.
Psychiatry 66, 773–784.
VandeVoort, C.A., Hill, D.L., Chaffin, C.L., Conley, A.J., 2011.
Ethanol, acetaldehyde, and estradiol affect growth and differ-
entiation of rhesus monkey embryonic stem cells. Alcohol. Clin.
Exp. Res. 35, 1534–1540.
Vangipuram, S.D., Lyman,W.D., 2012. Ethanol affects differentiation-
related pathways and suppresses Wnt signaling protein expression
in human neural stem cells. Alcohol. Clin. Exp. Res. 36, 788–797.
Wang, G.G., Yao, J.C., Worah, S., White, J.A., Luna, R., Wu, T.T.,
Hamilton, S.R., Rashid, A., 2005. Comparison of genetic
alterations in neuroendocrine tumors: frequent loss of
chromosome 18 in ileal carcinoid tumors. Mod. Pathol. 18,
1079–1087.
Wang, Z., Oron, E., Nelson, B., Razis, S., Ivanova, N., 2012. Distinct
lineage specification roles for NANOG, OCT4, and SOX2 in human
embryonic stem cells. Cell Stem Cell 10, 440–454.
806 O. Khalid et al.Wasserman, W.W., Sandelin, A., 2004. Applied bioinformatics for the
identification of regulatory elements. Nat. Rev. Genet. 5, 276–287.
Windham, G.C., Von Behren, J., Fenster, L., Schaefer, C., Swan, S.
H., 1997. Moderate maternal alcohol consumption and risk of
spontaneous abortion. Epidemiology 8, 509–514.
Wozniak, D.F., Hartman, R.E., Boyle, M.P., Vogt, S.K., Brooks, A.R.,
Tenkova, T., Young, C., Olney, J.W., Muglia, L.J., 2004. Apoptotic
neurodegeneration induced by ethanol in neonatal mice is
associated with profound learning/memory deficits in juveniles
followed by progressive functional recovery in adults. Neurobiol.
Dis. 17, 403–414.
Wu, B.T., Su, Y.H., Tsai, M.T., Wasserman, S.M., Topper, J.N.,
Yang, R.B., 2004. A novel secreted, cell-surface glycoprotein
containing multiple epidermal growth factor-like repeats and
one CUB domain is highly expressed in primary osteoblasts and
bones. J. Biol. Chem. 279, 37485–37490.
Xu, C., Inokuma, M.S., Denham, J., Golds, K., Kundu, P., Gold, J.D.,
Carpenter, M.K., 2001. Feeder-free growth of undifferentiated
human embryonic stem cells. Nat. Biotechnol. 19, 971–974.
Yang, H.Y., Cheng, C.F., Djoko, B., Lian, W.S., Tu, C.F., Tsai, M.T.,
Chen, Y.H., Chen, C.C., Cheng, C.J., Yang, R.B., 2007. Transgenic
overexpression of the secreted, extracellular EGF–CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice.
Cardiovasc. Res. 75, 139–147.
Yu, G., Wang, L.G., Han, Y., He, Q.Y., 2012. clusterProfiler: an R
package for comparing biological themes among gene clusters.
OMICS 16, 284–287.
Zeisel, S.H., 2011. What choline metabolism can tell us about the
underlying mechanisms of fetal alcohol spectrum disorders. Mol.
Neurobiol. 44, 185–191.
Zhang, B., Horvath, S., 2005. A general framework for weighted
gene co-expression network analysis. Stat. Appl. Genet. Mol.
Biol. 4 (Article17).
Zhao, X., Pak, C., Smrt, R.D., Jin, P., 2007. Epigenetics and Neural
developmental disorders: Washington DC, September 18 and 19,
2006. Epigenetics 2, 126–134.
Zhou, G.P., Wong, C., Su, R., Crable, S.C., Anderson, K.P., Gallagher,
P.G., 2004. Human potassium chloride cotransporter 1 (SLC12A4)
promoter is regulated by AP-2 and contains a functional down-
stream promoter element. Blood 103, 4302–4309.
Zhou, F.C., Balaraman, Y., Teng, M., Liu, Y., Singh, R.P., Nephew, K.P.,
2011. Alcohol alters DNA methylation patterns and inhibits neural
stem cell differentiation. Alcohol. Clin. Exp. Res. 35, 735–746.
